Hematology News‘Exciting’: Post-SCT, antiviral T-cell therapy shows promiseFebruary 3, 2023TransplantMixed Topics
Hematology NewsMCL: Ibrutinib could become the ‘new standard’December 12, 2022Mantle Cell LymphomaTransplant
Hematology News‘Astonishing’ results: Skip salvage chemo, proceed to HSCTDecember 11, 2022AMLTransplant
Hematology NewsPost-transplant diet: Gruel no longer rulesDecember 11, 2022TransplantPatient & Survivor Care
Hematology NewsPoorly matched stem cell transplants linked to ancestryDecember 10, 2022TransplantDiversity in MedicinePatient & Survivor Care
Hematology NewsASH 2022: New clinical data challenge long-held assumptionsDecember 7, 2022Mixed TopicsTransplantHodgkin LymphomaALLPatient & Survivor CareMantle Cell LymphomaAML
Hematology NewsTransplant provides no clear survival benefit in real-world MCL studyDecember 5, 2022Mantle Cell LymphomaTransplant
Hematology NewsBlame MCL, not transplantation, for late effects?November 18, 2022Mantle Cell LymphomaTransplant
Hematology NewsBias and other barriers to HSCT accessSeptember 1, 2022Multiple MyelomaTransplantMixed TopicsAMLMyelodysplastic Syndrome
Hematology NewsFirst drug therapy approved for childhood GVHDAugust 26, 2022ALLAMLMixed TopicsPediatricsCLLMantle Cell LymphomaTransplant
Hematology NewsFewer transplants for MM with quadruplet therapy?August 1, 2022Multiple MyelomaTransplant
Hematology NewsEvusheld for COVID-19: Lifesaving and free, but still few takersAugust 1, 2022COVID-19 UpdatesPreventive CareTransplant
